Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea
- PMID: 9952285
- DOI: 10.1016/s0024-3205(98)00406-8
Growth inhibition of leukemic cells by (-)-epigallocatechin gallate, the main constituent of green tea
Abstract
In this report, we presented the results that EGCG, the main constituent of the polyphenols present in Japanese green tea inhibited growth of leukemic cell lines of both human and mice. The proliferation of human leukemic cell lines and mouse NFS60 cell line was inhibited by EGCG. Sensitivity of each line to EGCG was different, and more than 50% of DNA synthesis was reduced in all the cell lines in the presence of 50 microM EGCG. On the other hand, normal hematopoietic progenitor cells retained their natural function of supplying mature cells of various lineages in the presence of less than 10 microM EGCG in vitro. Even in the presence of 100 microM EGCG, half the colonies containing all the lineages of cells were developed. All the dead cells of each line showed characteristics of apoptosis, which might be due to inhibition by EGCG of growth factors' signaling. Besides anticarcinogenic activity, EGCG is expected to have a new function for leukemia therapy without side effects.
Similar articles
-
The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).Amino Acids. 2002;22(2):131-43. doi: 10.1007/s007260200002. Amino Acids. 2002. PMID: 12395181
-
Effect of (-)-epigallocatechin gallate on leukemic blast cells from patients with acute myeloblastic leukemia.Life Sci. 1997;60(2):135-42. doi: 10.1016/s0024-3205(96)00603-0. Life Sci. 1997. PMID: 9000119
-
Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction.Carcinogenesis. 2000 Nov;21(11):2035-9. doi: 10.1093/carcin/21.11.2035. Carcinogenesis. 2000. PMID: 11062165
-
Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.Clin Nutr. 2013 Dec;32(6):894-903. doi: 10.1016/j.clnu.2013.03.008. Epub 2013 Mar 15. Clin Nutr. 2013. PMID: 23582951 Review.
-
Cancer Prevention with Green Tea and Its Principal Constituent, EGCG: from Early Investigations to Current Focus on Human Cancer Stem Cells.Mol Cells. 2018 Feb 28;41(2):73-82. doi: 10.14348/molcells.2018.2227. Epub 2018 Jan 31. Mol Cells. 2018. PMID: 29429153 Free PMC article. Review.
Cited by
-
Activity of green tea polyphenol epigallocatechin-3-gallate against ovarian carcinoma cell lines.Cancer Res Treat. 2004 Oct;36(5):315-23. doi: 10.4143/crt.2004.36.5.315. Epub 2004 Oct 31. Cancer Res Treat. 2004. PMID: 20368822 Free PMC article.
-
Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.Blood. 2006 Oct 15;108(8):2804-10. doi: 10.1182/blood-2006-05-022814. Epub 2006 Jun 29. Blood. 2006. PMID: 16809610 Free PMC article.
-
(-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma.Breast Cancer Res. 2010;12(1):R8. doi: 10.1186/bcr2473. Epub 2010 Jan 15. Breast Cancer Res. 2010. PMID: 20078855 Free PMC article.
-
Epigallocatechin-3-gallate suppresses proinflammatory cytokines and chemokines induced by Toll-like receptor 9 agonists in prostate cancer cells.J Inflamm Res. 2014 Jun 17;7:89-101. doi: 10.2147/JIR.S61365. eCollection 2014. J Inflamm Res. 2014. PMID: 24971028 Free PMC article.
-
Effects of tea polyphenols on ovarian development in rats.J Endocrinol Invest. 2008 Dec;31(12):1110-8. doi: 10.1007/BF03345661. J Endocrinol Invest. 2008. PMID: 19246979
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical